Outcome for Advanced or Metastatic Soft Tissue Sarcoma of Nonextremities Treated with Doxorubicin-Based Chemotherapy: A Retrospective Study from a Single Cancer Institution

BACKGROUND: Doxorubicin is the key drug for treatment of advanced soft tissue sarcoma (STS). The appropriate dosage of doxorubicin, regarding monotherapy or the role of combination therapy, is unclear. METHODS: We retrospectively reviewed patients with advanced or metastatic STS of nonextremities wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Marshall, Shoko, Nakano, Kenji, Sugiura, Yoshiya, Taira, Shinichiro, Ono, Makiko, Tomomatsu, Junichi, Takahashi, Shunji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932429/
https://www.ncbi.nlm.nih.gov/pubmed/29849480
http://dx.doi.org/10.1155/2018/8926598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932429/
https://www.ncbi.nlm.nih.gov/pubmed/29849480
http://dx.doi.org/10.1155/2018/8926598

Ejemplares similares